Amorphous cabazitaxel

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9012665
APP PUB NO 20140228426A1
SERIAL NO

13952117

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to an amorphous form of cabazitaxel, which can be prepared by dissolving a solid form of cabazitaxel in an organic solvent, and removing the organic solvent to dryness. The amorphous form of cabazitaxel is characterized by DSC as in FIG. 1 and/or X-ray powder diffraction pattern as in FIG. 2.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YUNG SHIN PHARM IND CO LTD1191 SEC 1 CHUNG SHAN ROAD TACHIA TAICHUNG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Po-Wei Taichung, TW 6 6
Fang, Tung-Shen Taichung, TW 2 11
Huang, Tsang-Miao Changhua, TW 5 8
Hung, Yi-Ting Tainan, TW 2 11
Kung, Liang-Rern Hsinchu, TW 5 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 21, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00